Journal article
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
Abstract
BACKGROUND: Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowering treatment on the risk of major cardiovascular events by type 2 diabetes status, as well as by baseline levels of systolic blood pressure.
METHODS: We conducted a one-stage individual participant-level data meta-analysis of …
Authors
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Smith GD; Holman RR; Woodward M; Gupta A
Journal
The Lancet Diabetes & Endocrinology, Vol. 10, No. 9, pp. 645–654
Publisher
Elsevier
Publication Date
9 2022
DOI
10.1016/s2213-8587(22)00172-3
ISSN
2213-8587